These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 17459753

  • 1. Bacteremia in patients with febrile neutropenia after chemotherapy at a university medical center in Malaysia.
    Baskaran ND, Gan GG, Adeeba K, Sam IC.
    Int J Infect Dis; 2007 Nov; 11(6):513-7. PubMed ID: 17459753
    [Abstract] [Full Text] [Related]

  • 2. Third generation cephalosporin resistant Enterobacteriaceae and multidrug resistant gram-negative bacteria causing bacteremia in febrile neutropenia adult cancer patients in Lebanon, broad spectrum antibiotics use as a major risk factor, and correlation with poor prognosis.
    Moghnieh R, Estaitieh N, Mugharbil A, Jisr T, Abdallah DI, Ziade F, Sinno L, Ibrahim A.
    Front Cell Infect Microbiol; 2015 Nov; 5():11. PubMed ID: 25729741
    [Abstract] [Full Text] [Related]

  • 3. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K.
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [Abstract] [Full Text] [Related]

  • 4. Microbiological spectrum and susceptibility patterns of pathogens causing bacteraemia in paediatric febrile neutropenic oncology patients: comparison between two consecutive time periods with use of different antibiotic treatment protocols.
    Greenberg D, Moser A, Yagupsky P, Peled N, Hofman Y, Kapelushnik J, Leibovitz E.
    Int J Antimicrob Agents; 2005 Jun; 25(6):469-73. PubMed ID: 15890499
    [Abstract] [Full Text] [Related]

  • 5. Causative pathogens of fever in neutropenic patients at King Chulalongkorn Memorial Hospital.
    Roongpoovapatr P, Suankratay C.
    J Med Assoc Thai; 2010 Jul; 93(7):776-83. PubMed ID: 20649055
    [Abstract] [Full Text] [Related]

  • 6. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
    Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, Shalit I, Samra Z, Pitlik S, Konigsberger H, Weinberger M.
    Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
    [Abstract] [Full Text] [Related]

  • 7. [Microbiological isolates in patients with febrile neutropenia and hematological neoplasias].
    Figuera Esparza M, Carballo M, Silva M, Figueredo A, Avilán J.
    Rev Esp Quimioter; 2006 Sep; 19(3):247-51. PubMed ID: 17099792
    [Abstract] [Full Text] [Related]

  • 8. Bloodstream infections in febrile neutropenic patients: bacterial spectrum and antimicrobial susceptibility pattern.
    Butt T, Afzal RK, Ahmad RN, Salman M, Mahmood A, Anwar M.
    J Ayub Med Coll Abbottabad; 2004 Sep; 16(1):18-22. PubMed ID: 15125174
    [Abstract] [Full Text] [Related]

  • 9. [Management of 315neutropenic febrile episodes in a cancer center].
    Dutronc H, Billhot M, Dupon M, Eghbali H, Donamaria C, Dauchy FA, Reiffers J.
    Med Mal Infect; 2009 Jun; 39(6):388-93. PubMed ID: 19062208
    [Abstract] [Full Text] [Related]

  • 10. A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility.
    Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen JM, Dybdahl B, Meyer P, Hopen G, Løkeland T, Grøttum K, Vie W, Langeland N.
    Scand J Infect Dis; 2005 Jun; 37(6-7):455-64. PubMed ID: 16012006
    [Abstract] [Full Text] [Related]

  • 11. High-risk febrile neutropenia in Auckland 2003-2004: the influence of the microbiology laboratory on patient treatment and the use of pathogen-specific therapy.
    Ritchie S, Palmer S, Ellis-Pegler R.
    Intern Med J; 2007 Jan; 37(1):26-31. PubMed ID: 17199841
    [Abstract] [Full Text] [Related]

  • 12. Febrile neutropenia in cancer patients in a tertiary care medical center in Lebanon: microbial spectrum and outcome.
    Hamzeh F, Kanj SS, Uwaydah M.
    J Med Liban; 2000 Jan; 48(3):136-42. PubMed ID: 11268566
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility of bacteremic isolates from cancer patients with or without neutropenia at a medical center in southern Taiwan.
    Huang CC, Wu CJ, Wang LR, Lee HC, Chang CM, Lee NY, Chen TY, Ko WC.
    J Microbiol Immunol Infect; 2011 Oct; 44(5):376-81. PubMed ID: 21524977
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Applying the Multinational Association for Supportive Care in Cancer risk scoring in predicting outcome of febrile neutropenia patients in a cohort of patients.
    Baskaran ND, Gan GG, Adeeba K.
    Ann Hematol; 2008 Jul; 87(7):563-9. PubMed ID: 18437382
    [Abstract] [Full Text] [Related]

  • 16. [Bacteremia in hematological malignant disorders].
    Hammerstrøm J, Røym AL, Gran FW.
    Tidsskr Nor Laegeforen; 2008 Aug 14; 128(15):1655-9. PubMed ID: 18704131
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Risk assessment and microbiological profile of infections in paediatric cancer patients with febrile neutropenia.
    Latiff Z, Zulkifli SZ, Jamal R.
    Malays J Pathol; 2002 Dec 14; 24(2):83-9. PubMed ID: 12887165
    [Abstract] [Full Text] [Related]

  • 19. Clinical and microbiologic determinants of serious bloodstream infections in Egyptian pediatric cancer patients: a one-year study.
    El-Mahallawy H, Sidhom I, El-Din NH, Zamzam M, El-Lamie MM.
    Int J Infect Dis; 2005 Jan 14; 9(1):43-51. PubMed ID: 15603994
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
    Link H, Böhme A, Cornely OA, Höffken K, Kellner O, Kern WV, Mahlberg R, Maschmeyer G, Nowrousian MR, Ostermann H, Ruhnke M, Sezer O, Schiel X, Wilhelm M, Auner HW, Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society).
    Ann Hematol; 2003 Oct 14; 82 Suppl 2():S105-17. PubMed ID: 13680173
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.